FILTER CONTENT

Filters
Company Names

Research

  • 7investing logo next to the Avita Medical logo.
    By Published On: February 17, 2025

    AVITA Medical: 2025 Will Be an “Inflection Point Year”

    AVITA Medical is continuing to show signs of progress. Its recently-reported fourth quarter [...]

  • By Published On: September 16, 2024

    Upstart Issues Upbeat Guidance, But Issues Remain. Downgrading to “Hold”.

  • By Published On: August 19, 2024

    August 2024 Conviction Rating Review

  • By Published On: July 4, 2024

    NVIDIA in 2025: Surging Demand, Skyrocketing Revenues, and the Rise of Sovereign AI

  • 7investing logo next to the Upstart logo.
    By Published On: February 15, 2024

    My Notes From Upstart’s Full Year 2023 Results

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • 7investing logo next to the Rocket Lab logo.
    By Published On: September 15, 2023

    Rocket Lab Moves Upmarket; Upgrading to “Best Buy”

  • 7investing logo next to the Upstart logo.
    By Published On: August 9, 2023

    A Detailed Look At Upstart’s Q2 2023 Report

  • By Published On: July 13, 2023

    Rocket Lab is Hitting an Important Inflection Point

  • By Published On: July 12, 2023

    Will SoFi Actually Become a Top 10 US Bank?

  • By Published On: July 11, 2023

    Is NVIDIA Worth Its Trillion-Dollar Valuation?

  • 7investing logo next to the Rocket Lab logo.
    By Published On: July 10, 2023

    Rocket Lab’s Rockets: Faster, Larger, and Now Reusable

  • 7investing logo next to the Upstart logo.
    By Published On: May 14, 2023

    Upstart Q1 2023: Some Green Shoots

  • 7investing logo next to the Upstart logo.
    By Published On: February 15, 2023

    Navigating Macro Headwinds: Upstart’s Path to Growth

  • Stock market charts with green arrow going up and red arrow going down
    By Published On: January 30, 2023

    SoFi’s Latest Monster Quarter Could Mark an Inflection Point

  • By Published On: December 19, 2022

    7investing’s 2022 Year in Review: An Updated Look at All of Our Stock Picks